U.S. Point Of Care Diagnostics Market Size & Outlook
Related Markets
U.S. point of care diagnostics market highlights
- The U.S. point of care diagnostics market generated a revenue of USD 8,148.1 million in 2025 and is expected to reach USD 10,265.0 million by 2033.
- The U.S. market is expected to grow at a CAGR of 2.9% from 2026 to 2033.
- In terms of segment, infectious disease was the largest revenue generating product in 2025.
- Fertility/Pregnancy is the most lucrative product segment registering the fastest growth during the forecast period.
Point of care diagnostics market data book summary
| Market revenue in 2025 | USD 8,148.1 million |
| Market revenue in 2033 | USD 10,265.0 million |
| Growth rate | 2.9% (CAGR from 2026 to 2033) |
| Largest segment | Infectious disease |
| Fastest growing segment | Fertility/Pregnancy |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuse (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.4% of the global point of care diagnostics market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. point of care diagnostics market is projected to lead the regional market in terms of revenue in 2033.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,575.8 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Point Of Care Diagnostics Market Scope
Point Of Care Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Accubiotech Co. | View profile | 11-50 | Shunyi, Beijing, China, Asia | https://www.accubiotech.com |
| Anbio Biotechnology | View profile | 1001-5000 | Frankfurt, Hessen, Germany, Europe | https://www.anbio.com/ |
| Alpha Laboratories | View profile | 11-50 | Eastleigh, Hampshire, United Kingdom, Europe | https://www.alphalabs.co.uk |
| Trinity Biotech | View profile | 251-500 | Bray, Wicklow, Ireland, Europe | http://trinitybiotech.com |
| Siemens Healthcare GmbH | View profile | - | - | - |
| Orasure Technologies | View profile | - | - | - |
| Abbott | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| Sekisui Diagnostics | View profile | 501-1000 | Lexington, Massachusetts, United States, North America | https://sekisuidiagnostics.com |
| Spectral Medical Inc | View profile | 29 | 135 The West Mall, Unit 2, Finance, Toronto, ON, Canada, M9C 1C2 | https://www.spectraldx.com |
| Trividia Health | View profile | 501-1000 | Fort Lauderdale, Florida, United States, North America | http://trividiahealth.com |
| Werfen | View profile | 5001-10000 | Barcelona, Catalonia, Spain, Europe | http://www.werfen.com/ |
| Nova Biomedical | View profile | 501-1000 | Waltham, Massachusetts, United States, North America | http://www.novabio.us |
| EKF Diagnostics Holdings PLC | View profile | 356 | 19 Stanwell Road, Penarth, Avon House, Cardiff, United Kingdom, CF64 2EZ | https://www.ekfdiagnostics.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| QuidelOrtho Corp | View profile | 7100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | https://www.quidelortho.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
U.S. point of care diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point of care diagnostics market will help companies and investors design strategic landscapes.
Infectious disease was the largest segment with a revenue share of 40.14% in 2025. Horizon Databook has segmented the U.S. point of care diagnostics market based on glucose testing, hb1ac testing, coagulation testing, fertility/pregnancy, infectious disease, cardiac markers, thyroid stimulating hormone, hematology, primary care systems, decentralized clinical chemistry, feces, lipid testing, cancer marker, blood gas/electrolytes, ambulatory chemistry, drug of abuse (doa) testing, autoimmune diseases, urinalysis/nephrology covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to U.S. point of care diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. point of care diagnostics market databook
-
Our clientele includes a mix of point of care diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. point of care diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. point of care diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. point of care diagnostics market size, by product, 2021-2033 (US$M)
U.S. Point Of Care Diagnostics Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
